Etoposide-based treatment of adult HLH is associated with high biochemical response but poor survival outcomes.

Nicholson, Matthew C; Naeije, Leonie; Hayden, Anna R; Mattman, Andre; Dix, David; Chen, Luke Y C

Nicholson, Matthew C; Naeije, Leonie; Hayden, Anna R; Mattman, Andre; Dix, David; Chen, Luke Y C.

Afiliação

Nicholson MC; Division of Hematology, Department of Medicine University of British Columbia Vancouver BC Canada.
Naeije L; Division of Hematology, Oncology and Bone Marrow Transplant, Department of Paediatrics University of British Columbia Vancouver BC Canada.
Hayden AR; Division of Hematology, Department of Medicine University of British Columbia Vancouver BC Canada.
Mattman A; Department of Pathology and Laboratory Medicine University of British Columbia Vancouver Canada.
Dix D; Division of Hematology, Oncology and Bone Marrow Transplant, Department of Paediatrics University of British Columbia Vancouver BC Canada.
Chen LYC; Division of Hematology, Department of Medicine University of British Columbia Vancouver BC Canada.

EJHaem ; 1(1): 277-280, 2020 Jul.

Article em En | MEDLINE | ID: mdl-35847699

Palavras-chave

HLH; etoposide; ferritin; hemophagocytic; soluble interleukin2 receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google